Eli Lilly +1.5% Reclaims $1,050, Institutional Buying Supports Momentum
$Eli Lilly(LLY)$
Eli Lilly (LLY) Rallies +1.45%: Pharma Giant Reclaims $1050+ Territory, Institutional Momentum Builds
Latest Close Data
LLY closed at $1,056.88 (+1.45%, +$15.09) on December 19th, reclaiming the $1,050+ level after trading in a $1,039.54-$1,079.26 range.
The stock sits 5.0% below its 52-week high of $1,111.99, showing resilience in the biotech sector.
Core Market Drivers
Strong institutional capital inflows of $200M net (+$1.211B inflow vs $1.191B outflow) signal renewed confidence in LLY's diabetes/obesity portfolio.
The pharma sector benefited from year-end positioning as investors rotate into healthcare defensives.
Recent GLP-1 market expansion and Medicare negotiations provide tailwinds.
Technical Analysis
Volume of 3.85M shares (0.95x average) suggests moderate participation.
RSI-6 at 63.09 indicates healthy bullish momentum without overbought conditions.
MACD shows improving convergence with DIF at 21.54 and narrowing negative histogram (-8.17), signaling potential upward momentum building.
Key Price Levels
Primary Support: $1,039.54 (today's low)
Strong Resistance: $1,079.26 (today's high)
Immediate Pivot: $1,050.00 (psychological level)
Valuation Perspective
Trading at 51.7x TTM P/E vs industry average of ~25x, reflecting premium for growth.
Forward P/E of 43.76 shows improvement from historical average of 52.71, suggesting earnings acceleration potential.
Analyst Targets
30 analysts maintain bullish stance: 10 Strong Buy, 15 Buy, 8 Hold. Average target price of $1,087 (+2.8% upside) with range of $706-$1,500, indicating strong institutional conviction.
Weekly Outlook
Expect consolidation in $1,040-$1,080 range near-term. Break above $1,080 targets $1,100+ retest, while failure below $1,040 could see pullback toward $1,000 support.
Risk Disclaimer
This analysis is for informational purposes only. Past performance does not guarantee future results. Please conduct your own research and consult financial advisors before making investment decisions.
For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.
🎉Cash Boost Account Now Supports 35,000+ Stocks & ETFs – Greater Flexibility Now
Find out more here.
Complete your first Cash Boost Account trade with a trade amount of ≥ SGD1000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.
Other helpful links:
💰Join the TB Contra Telegram Group to Get $10 Trading Vouchers Now🎉
How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
